Long-Term Outcomes of Ledipasvir/Sofosbuvir Treatment in Hepatitis C: Viral Suppression, Hepatocellular Carcinoma, and Mortality in Mongolia

Long-Term Outcomes of Ledipasvir/Sofosbuvir Treatment in Hepatitis C: Viral Suppression, Hepatocellular Carcinoma, and Mortality in Mongolia

(1) Background: Hepatitis C virus (HCV) infection poses a significant health burden, particularly in Mongolia, where the HCV prevalence is notably high. This study evaluates the long-term outcomes of HCV treatment with ledipasvir/sofosbuvir, focusing on mortality, viral relapse, and hepatocellular c...

Full description

Saved in:
Bibliographic Details
Main Authors: Amgalan Byambasuren, Buyankhishig Gyarvuulkhasuren, Byambatsogt Erdenebat, Khurelbaatar Nyamdavaa, Oidov Baatarkhuu
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Viruses
Subjects:
viral suppression
liver cirrhosis
chronic liver disease
antiviral therapy
Online Access:https://www.mdpi.com/1999-4915/17/6/743
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items